Exactly, if the world is still as we know it, revenue generating mass production should commence in 2025 so at the current SP it’s an attractive proposition for those prepared for the risk.
Burns is still a slimeball though, we’ll see if he maintains the 3000T production sales pitch or comes clean & admits delays until 2025.
I’d rather be wrong and an additional $30m revenue generated in 2024 but history shows Chris has failed every timeline presented to shareholders to date so why change now
- Forums
- ASX - By Stock
- NVX
- Media Watch - NVX related
Media Watch - NVX related, page-14563
Featured News
Add NVX (ASX) to my watchlist
(20min delay)
|
|||||
Last
78.0¢ |
Change
-0.010(1.27%) |
Mkt cap ! $385.1M |
Open | High | Low | Value | Volume |
78.0¢ | 80.5¢ | 77.5¢ | $922.5K | 1.172M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 16461 | 78.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
78.5¢ | 2992 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 16461 | 0.780 |
3 | 55848 | 0.775 |
9 | 142248 | 0.770 |
11 | 143195 | 0.765 |
11 | 213697 | 0.760 |
Price($) | Vol. | No. |
---|---|---|
0.790 | 20603 | 2 |
0.795 | 43195 | 1 |
0.800 | 55352 | 4 |
0.805 | 50629 | 3 |
0.810 | 46100 | 3 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
NVX (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online